Hemostemix Inc. – TSX:HEM.V

Hemostemix stock price today

CAD 0.2
+0.13
+185.71%
Financial Health
0
1
2
3
4
5
6
7
8
9

Hemostemix stock price monthly change

+16.67%
month

Hemostemix stock price quarterly change

+16.67%
quarter

Hemostemix key metrics

Market Cap
 8.29M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -0.02
Revenue
 N/A
EBITDA
 -1.41M
Income
 -1.70M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Hemostemix stock price history

Hemostemix stock forecast

Hemostemix financial statements

Profit Margin

Hemostemix Inc. (TSX:HEM.V): Profit margin
Jun 2023 0 -284.94K
Sep 2023 0 -257.24K
Dec 2023 0 -683.58K
Mar 2024 0 -475.53K
HEM.V income statement history

Debt to Assets

Hemostemix Inc. (TSX:HEM.V): Debt to assets
Jun 2023 305114 7.18M 2356.49%
Sep 2023 701148 7.55M 1077.36%
Dec 2023 313765 7.68M 2449.28%
Mar 2024 94361 7.93M 8411.29%
HEM.V balance sheet history

Cash Flow

Hemostemix Inc. (TSX:HEM.V): Cash Flow
Jun 2023 -401.75K 0 283.73K
Sep 2023 -66.14K 0 289.40K
Dec 2023 -240.48K 0 18.31K
Mar 2024 -120.34K 0 0
HEM.V cash flow history

Hemostemix other data

Frequently Asked Questions (FAQ)

  • What's the price of Hemostemix stock today?

    One share of Hemostemix stock can currently be purchased for approximately $0.2.

  • When is Hemostemix's next earnings date?

    Unfortunately, Hemostemix's (HEM.V) next earnings date is currently unknown.

  • Does Hemostemix pay dividends?

    No, Hemostemix does not pay dividends.

  • How much money does Hemostemix make?

    Hemostemix has a market capitalization of 8.29M.

  • What is Hemostemix's stock symbol?

    Hemostemix Inc. is traded on the TSX under the ticker symbol "HEM.V".

  • What is Hemostemix's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Hemostemix?

    Shares of Hemostemix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Hemostemix went public?

    Hemostemix Inc. is publicly traded company for more then 10 years since IPO on 28 Nov 2014.

  • What is Hemostemix's official website?

    The official website for Hemostemix is hemostemix.com.

  • Where are Hemostemix's headquarters?

    Hemostemix is headquartered at 707-7th Avenue SW, Calgary, AB.

  • How can i contact Hemostemix?

    Hemostemix's mailing address is 707-7th Avenue SW, Calgary, AB.

Hemostemix company profile:

Hemostemix Inc.

hemostemix.com
Exchange:

TSX

Full time employees:

0

Industry:

Biotechnology

Sector:

Healthcare

Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases. The company is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.

707-7th Avenue SW
Calgary, AB T2P 3H6

:
ISIN: CA4236943060
: